- Home
- GLBS vs APM Comparison
GLBS vs APM Comparison
Compare GLBS & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- APM
- Stock Information
- Founded
- GLBS 2006
- APM 2010
- Country
- GLBS Greece
- APM United Kingdom
- Employees
- GLBS N/A
- APM N/A
- Industry
- GLBS Marine Transportation
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- GLBS Consumer Discretionary
- APM Health Care
- Exchange
- GLBS Nasdaq
- APM Nasdaq
- Market Cap
- GLBS 21.4M
- APM 18.9M
- IPO Year
- GLBS 2007
- APM 2018
- Fundamental
- Price
- GLBS $1.05
- APM $1.98
- Analyst Decision
- GLBS Strong Buy
- APM
- Analyst Count
- GLBS 1
- APM 0
- Target Price
- GLBS $3.00
- APM N/A
- AVG Volume (30 Days)
- GLBS 37.0K
- APM 20.5M
- Earning Date
- GLBS 09-12-2025
- APM 04-30-2025
- Dividend Yield
- GLBS N/A
- APM N/A
- EPS Growth
- GLBS N/A
- APM N/A
- EPS
- GLBS N/A
- APM N/A
- Revenue
- GLBS $35,776,000.00
- APM N/A
- Revenue This Year
- GLBS $5.01
- APM N/A
- Revenue Next Year
- GLBS $27.86
- APM N/A
- P/E Ratio
- GLBS N/A
- APM N/A
- Revenue Growth
- GLBS 17.92
- APM N/A
- 52 Week Low
- GLBS $0.99
- APM $0.46
- 52 Week High
- GLBS $2.21
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- GLBS 50.70
- APM 52.67
- Support Level
- GLBS $1.00
- APM $1.64
- Resistance Level
- GLBS $1.09
- APM $2.65
- Average True Range (ATR)
- GLBS 0.04
- APM 0.21
- MACD
- GLBS 0.01
- APM -0.05
- Stochastic Oscillator
- GLBS 56.33
- APM 33.66
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.